Amphastar Pharmaceuticals (AMPH) Cash & Equivalents (2013 - 2026)
Amphastar Pharmaceuticals' Cash & Equivalents came in at $223.61 million for Q2 2026, up 19.1% from $187.69 million a year earlier and up 30.8% from the prior quarter.
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Cash & Equivalents (2013 - 2026) Analysis & Trends
At the end of FY2025, Amphastar Pharmaceuticals' Cash & Equivalents was $170.18 million, up 12.2% from FY2024.
- Cash & Equivalents carries a five-year compound annual growth rate of 12.9% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $151.61 million in FY2024 (+5.1%), $144.3 million in FY2023 (-7.6%), $156.1 million in FY2022 (+23.5%) and $126.35 million in FY2021 (+36.4%).
- The Q2 2026 figure represents the highest quarterly Cash & Equivalents since Q3 2023.
- Year-over-year, Cash & Equivalents increased in four of the last eight quarters, with growth averaging 0.6%.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q1 2022 (growth of 69.9%), and the weakest in Q3 2024 (a decline of 28.0%).
- Business Quant data shows AMPH's Cash & Equivalents at $170.94 million (Q1 2026), $170.18 million (Q4 2025) and $216.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Amphastar Pharmaceuticals | 1.08 Bn | -59.50 Mn | 93.47 Mn | 223.61 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 223.61 Mn |
| Mar 31, 2026 | 170.94 Mn |
| Dec 31, 2025 | 170.18 Mn |
| Sep 30, 2025 | 216.27 Mn |
| Jun 30, 2025 | 187.69 Mn |
| Mar 31, 2025 | 182.78 Mn |
| Dec 31, 2024 | 151.61 Mn |
| Sep 30, 2024 | 192.12 Mn |
| Jun 30, 2024 | 189.62 Mn |
| Mar 31, 2024 | 201.15 Mn |
| Dec 31, 2023 | 144.30 Mn |
| Sep 30, 2023 | 266.78 Mn |
| Jun 30, 2023 | 148.60 Mn |
| Mar 31, 2023 | 176.62 Mn |
| Dec 31, 2022 | 156.10 Mn |
| Sep 30, 2022 | 157.24 Mn |
| Jun 30, 2022 | 166.16 Mn |
| Mar 31, 2022 | 172.63 Mn |
| Dec 31, 2021 | 126.35 Mn |
| Sep 30, 2021 | 106.61 Mn |
API Access
Amphastar Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "AMPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=AMPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();